NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.33
Delayed Data
As of Apr 20
 -0.016 / -0.48%
Today’s Change
2.25
Today|||52-Week Range
5.00
-13.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-15.2M-19.0M-13.2M-7.4M
 
 
 
 
 
Depreciation232.0K164.0K114.0K95.0K
 
 
 
 
 
Total Other Cash Flow-636.0K-768.0K4.1M2.6M
 
 
 
 
 
Funds From Operations-15.6M-19.6M-9.0M-4.7M
 
 
 
 
 
Funds From/For Other Operating Expenses-543.0K-1.0M3.2M1.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-15.1M-18.6M-12.1M-6.3M
 
 
 
 
 
 
InvestingIncrease In Investments-4.0M0.000.000.00
 
 
Decrease In Investments6.6M0.000.000.00
 
 
Capital Expenditures-68.0K-123.0K-160.0K-244.0K
 
 
 
 
 
Fixed Asset Disposal128.0K37.0K0.000.00
 
 
 
Net Cash Flow Investing2.6M-86.0K-160.0K-244.0K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.001.7M1.4M0.00
 
 
 
Long Term Debt Reduction0.00---3.0M0.00
 
 
Net Proceeds Stock Sale7.4M13.9M21.1M249.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.0048.0K
 
 
Net Cash Flow - Financing7.4M15.6M19.4M201.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-5.1M-3.0M7.1M-6.3M